GENE ONLINE|News &
Opinion
Blog

Tirzepatide
GLP-1 Drugs, Metabolic Medicine, and the $200B Weight-Loss War
2025-07-30
Comparative Analysis of Tirzepatide (Zepbound/Mounjaro) and Semaglutide (Wegovy) for Weight Loss
2025-05-12
Novo Nordisk Takes on Eli Lilly in Weight Loss Drug Battle with Wegovy Price Cut
2025-03-06
Lilly Slashes Zepbound Vial Prices by Up to 50% to Expand Access for Uninsured Patients
2025-02-26
FDA to Reassess Shortage Status of Key Obesity Drugs; Compounding Stocks Out of the Red—for Now
2024-10-16
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Eli Lilly Breaks Records with $9B Total Investment in Indiana Weight-loss Drug Expansion
2024-05-27
Obesity Hope or Hype: Leveraging the Efficacy of Mainstream Weight Loss Pills (Second Part)
2024-03-07
Obesity Hope or Hype: Leveraging the Efficacy of Mainstream Weight Loss Pills (First Part)
2024-02-15
Long Standing Rivalry in Diabetes Market Intensifies as Eli Lilly’s Drug Outshines Novo’s in Head to Head Trial
2021-03-05
LATEST
Parul Butala Appointed President of AMERCO Real Estate Company
2026-07-21
Jonathan Saunders Appointed Executive Creative Director of Kate Spade New York
2026-07-21
WDIV Opens Hybrid Newsroom and Coffee Shop in Downtown Plymouth
2026-07-21
Caesars Palace Launches 1966-Inspired Menus for 60th Anniversary Celebration
2026-07-21
Starco Brands Completes Acquisition of Custom Bakehouse
2026-07-21
FDA Grants Emergency Use Authorization for Seegene Multiplex PCR Assay Detecting Four Viruses
2026-07-21
Urologist Elizabeth Dray Finds No Basis for Linking Homeric Heroism to Modern Testosterone Screening
2026-07-21
Scroll to Top